Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial
- Author
- KWAKU POKU ASANTE1 2 ; ABDULLA, Salim3 ; SALIM, Nahya3 ; FERNANDES, Jose F4 5 ; DOSOO, David1 ; CHIKAWE, Maria3 ; ISSIFOU, Saadou4 5 ; OSEI-KWAKYE, Kingsley1 ; LIEVENS, Marc6 ; PARICEK, Maria4 5 ; MOLLER, Tina5 ; APANGA, Stephen1 ; AGNANDJI, Selidji4 5 ; MWANGOKA, Grace3 ; DUBOIS, Marie-Claude6 ; MADI, Tigani4 5 ; KWARA, Evans1 ; MINJA, Rose3 ; HOUNKPATIN, Aurore B4 5 ; BOAHEN, Owusu1 ; KAYAN, Kingsley1 ; ADJEI, George1 ; CHANDRAMOHAN, Daniel2 ; LYIMO, John3 ; CARTER, Terrell7 ; VANSADIA, Preeti7 ; SILLMAN, Marla7 ; SAVARESE, Barbara7 ; LOUCQ, Christian7 ; LAPIERRE, Didier6 ; GREENWOOD, Brian2 ; COHEN, Joe6 ; KREMSNER, Peter4 5 ; OWUSU-AGYEI, Seth1 2 ; VEKEMANS, Johan6 ; TANNER, Marcel3 8 ; LELL, Bertrand4 5 ; SOULANOUDJINGAR, Solange4 5 ; OWUSU, Ruth1 ; SHOMARI, Mwanajaa3 ; LEACH, Amanda6 ; JONGERT, Erik6
[1] Kintampo Health Research Centre, Kintampo, Ghana
[2] School of Hygiene and Tropical Medicine, London, United Kingdom
[3] Ifakara Health Institute, Bagamoyo, China
[4] Research Unit, Albert Schweitzer Hospital, Lambarene, Gabon
[5] Institute of Tropical Medicine, University of Tübingen, Tubingen, Germany
[6] Biologicals, Rixensart, Belgium
[7] PATH Malaria Vaccine Initiative, Washington, DC, United States
[8] SwissTropical and Public Health Institute and University of Basel, Basel, Switzerland - Source
Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, 9 p ; ref : 26 ref
- ISSN
- 1473-3099
- Scientific domain
- General medicine general surgery; Microbiology, infectious diseases
- Publisher
- Lancet Publishing Group, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Immunoprophylaxie Paludisme Prévention Vaccin Vaccination Infection Parasitose Protozoose
- Keyword (en)
- Immunoprophylaxis Malaria Prevention Vaccine Vaccination Infection Parasitosis Protozoal disease
- Keyword (es)
- Inmunoprofilaxia Paludismo Prevención Vacuna Vacunación Infección Parasitosis Protozoosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05E Parasitic diseases / 002B05E02 Protozoal diseases / 002B05E02B Human protozoal diseases / 002B05E02B4 Malaria
- Discipline
- Infectious pathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 24578533
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/S1473-3099(11)70100-1 
https://dx.doi.org/10.1016/S1473-3099(11)70100-1
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"749\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"KWAKU POKU ASANTE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:41:{i:0;s:14:\"ABDULLA, Salim\";i:1;s:12:\"SALIM, Nahya\";i:2;s:17:\"FERNANDES, Jose F\";i:3;s:12:\"DOSOO, David\";i:4;s:14:\"CHIKAWE, Maria\";i:5;s:15:\"ISSIFOU, Saadou\";i:6;s:21:\"OSEI-KWAKYE, Kingsley\";i:7;s:13:\"LIEVENS, Marc\";i:8;s:14:\"PARICEK, Maria\";i:9;s:12:\"MOLLER, Tina\";i:10;s:15:\"APANGA, Stephen\";i:11;s:17:\"AGNANDJI, Selidji\";i:12;s:15:\"MWANGOKA, Grace\";i:13;s:20:\"DUBOIS, Marie-Claude\";i:14;s:12:\"MADI, Tigani\";i:15;s:12:\"KWARA, Evans\";i:16;s:11:\"MINJA, Rose\";i:17;s:20:\"HOUNKPATIN, Aurore B\";i:18;s:13:\"BOAHEN, Owusu\";i:19;s:15:\"KAYAN, Kingsley\";i:20;s:13:\"ADJEI, George\";i:21;s:20:\"CHANDRAMOHAN, Daniel\";i:22;s:11:\"LYIMO, John\";i:23;s:15:\"CARTER, Terrell\";i:24;s:16:\"VANSADIA, Preeti\";i:25;s:14:\"SILLMAN, Marla\";i:26;s:17:\"SAVARESE, Barbara\";i:27;s:16:\"LOUCQ, Christian\";i:28;s:16:\"LAPIERRE, Didier\";i:29;s:16:\"GREENWOOD, Brian\";i:30;s:10:\"COHEN, Joe\";i:31;s:15:\"KREMSNER, Peter\";i:32;s:17:\"OWUSU-AGYEI, Seth\";i:33;s:15:\"VEKEMANS, Johan\";i:34;s:14:\"TANNER, Marcel\";i:35;s:14:\"LELL, Bertrand\";i:36;s:24:\"SOULANOUDJINGAR, Solange\";i:37;s:11:\"OWUSU, Ruth\";i:38;s:17:\"SHOMARI, Mwanajaa\";i:39;s:13:\"LEACH, Amanda\";i:40;s:13:\"JONGERT, Erik\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"749\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"KWAKU POKU ASANTE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:41:{i:0;s:14:\"ABDULLA, Salim\";i:1;s:12:\"SALIM, Nahya\";i:2;s:17:\"FERNANDES, Jose F\";i:3;s:12:\"DOSOO, David\";i:4;s:14:\"CHIKAWE, Maria\";i:5;s:15:\"ISSIFOU, Saadou\";i:6;s:21:\"OSEI-KWAKYE, Kingsley\";i:7;s:13:\"LIEVENS, Marc\";i:8;s:14:\"PARICEK, Maria\";i:9;s:12:\"MOLLER, Tina\";i:10;s:15:\"APANGA, Stephen\";i:11;s:17:\"AGNANDJI, Selidji\";i:12;s:15:\"MWANGOKA, Grace\";i:13;s:20:\"DUBOIS, Marie-Claude\";i:14;s:12:\"MADI, Tigani\";i:15;s:12:\"KWARA, Evans\";i:16;s:11:\"MINJA, Rose\";i:17;s:20:\"HOUNKPATIN, Aurore B\";i:18;s:13:\"BOAHEN, Owusu\";i:19;s:15:\"KAYAN, Kingsley\";i:20;s:13:\"ADJEI, George\";i:21;s:20:\"CHANDRAMOHAN, Daniel\";i:22;s:11:\"LYIMO, John\";i:23;s:15:\"CARTER, Terrell\";i:24;s:16:\"VANSADIA, Preeti\";i:25;s:14:\"SILLMAN, Marla\";i:26;s:17:\"SAVARESE, Barbara\";i:27;s:16:\"LOUCQ, Christian\";i:28;s:16:\"LAPIERRE, Didier\";i:29;s:16:\"GREENWOOD, Brian\";i:30;s:10:\"COHEN, Joe\";i:31;s:15:\"KREMSNER, Peter\";i:32;s:17:\"OWUSU-AGYEI, Seth\";i:33;s:15:\"VEKEMANS, Johan\";i:34;s:14:\"TANNER, Marcel\";i:35;s:14:\"LELL, Bertrand\";i:36;s:24:\"SOULANOUDJINGAR, Solange\";i:37;s:11:\"OWUSU, Ruth\";i:38;s:17:\"SHOMARI, Mwanajaa\";i:39;s:13:\"LEACH, Amanda\";i:40;s:13:\"JONGERT, Erik\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"749\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"KWAKU POKU ASANTE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:41:{i:0;s:14:\"ABDULLA, Salim\";i:1;s:12:\"SALIM, Nahya\";i:2;s:17:\"FERNANDES, Jose F\";i:3;s:12:\"DOSOO, David\";i:4;s:14:\"CHIKAWE, Maria\";i:5;s:15:\"ISSIFOU, Saadou\";i:6;s:21:\"OSEI-KWAKYE, Kingsley\";i:7;s:13:\"LIEVENS, Marc\";i:8;s:14:\"PARICEK, Maria\";i:9;s:12:\"MOLLER, Tina\";i:10;s:15:\"APANGA, Stephen\";i:11;s:17:\"AGNANDJI, Selidji\";i:12;s:15:\"MWANGOKA, Grace\";i:13;s:20:\"DUBOIS, Marie-Claude\";i:14;s:12:\"MADI, Tigani\";i:15;s:12:\"KWARA, Evans\";i:16;s:11:\"MINJA, Rose\";i:17;s:20:\"HOUNKPATIN, Aurore B\";i:18;s:13:\"BOAHEN, Owusu\";i:19;s:15:\"KAYAN, Kingsley\";i:20;s:13:\"ADJEI, George\";i:21;s:20:\"CHANDRAMOHAN, Daniel\";i:22;s:11:\"LYIMO, John\";i:23;s:15:\"CARTER, Terrell\";i:24;s:16:\"VANSADIA, Preeti\";i:25;s:14:\"SILLMAN, Marla\";i:26;s:17:\"SAVARESE, Barbara\";i:27;s:16:\"LOUCQ, Christian\";i:28;s:16:\"LAPIERRE, Didier\";i:29;s:16:\"GREENWOOD, Brian\";i:30;s:10:\"COHEN, Joe\";i:31;s:15:\"KREMSNER, Peter\";i:32;s:17:\"OWUSU-AGYEI, Seth\";i:33;s:15:\"VEKEMANS, Johan\";i:34;s:14:\"TANNER, Marcel\";i:35;s:14:\"LELL, Bertrand\";i:36;s:24:\"SOULANOUDJINGAR, Solange\";i:37;s:11:\"OWUSU, Ruth\";i:38;s:17:\"SHOMARI, Mwanajaa\";i:39;s:13:\"LEACH, Amanda\";i:40;s:13:\"JONGERT, Erik\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"749\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"KWAKU POKU ASANTE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:41:{i:0;s:14:\"ABDULLA, Salim\";i:1;s:12:\"SALIM, Nahya\";i:2;s:17:\"FERNANDES, Jose F\";i:3;s:12:\"DOSOO, David\";i:4;s:14:\"CHIKAWE, Maria\";i:5;s:15:\"ISSIFOU, Saadou\";i:6;s:21:\"OSEI-KWAKYE, Kingsley\";i:7;s:13:\"LIEVENS, Marc\";i:8;s:14:\"PARICEK, Maria\";i:9;s:12:\"MOLLER, Tina\";i:10;s:15:\"APANGA, Stephen\";i:11;s:17:\"AGNANDJI, Selidji\";i:12;s:15:\"MWANGOKA, Grace\";i:13;s:20:\"DUBOIS, Marie-Claude\";i:14;s:12:\"MADI, Tigani\";i:15;s:12:\"KWARA, Evans\";i:16;s:11:\"MINJA, Rose\";i:17;s:20:\"HOUNKPATIN, Aurore B\";i:18;s:13:\"BOAHEN, Owusu\";i:19;s:15:\"KAYAN, Kingsley\";i:20;s:13:\"ADJEI, George\";i:21;s:20:\"CHANDRAMOHAN, Daniel\";i:22;s:11:\"LYIMO, John\";i:23;s:15:\"CARTER, Terrell\";i:24;s:16:\"VANSADIA, Preeti\";i:25;s:14:\"SILLMAN, Marla\";i:26;s:17:\"SAVARESE, Barbara\";i:27;s:16:\"LOUCQ, Christian\";i:28;s:16:\"LAPIERRE, Didier\";i:29;s:16:\"GREENWOOD, Brian\";i:30;s:10:\"COHEN, Joe\";i:31;s:15:\"KREMSNER, Peter\";i:32;s:17:\"OWUSU-AGYEI, Seth\";i:33;s:15:\"VEKEMANS, Johan\";i:34;s:14:\"TANNER, Marcel\";i:35;s:14:\"LELL, Bertrand\";i:36;s:24:\"SOULANOUDJINGAR, Solange\";i:37;s:11:\"OWUSU, Ruth\";i:38;s:17:\"SHOMARI, Mwanajaa\";i:39;s:13:\"LEACH, Amanda\";i:40;s:13:\"JONGERT, Erik\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S1473-3099(11)70100-1\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:9:\"\u0000*\u0000jtitle\";s:35:\"Lancet. Infectious diseases (print)\";s:9:\"\u0000*\u0000stitle\";s:28:\"Lancet. Infect. dis. (print)\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"11\";s:8:\"\u0000*\u0000issue\";s:2:\"10\";s:8:\"\u0000*\u0000spage\";s:3:\"741\";s:8:\"\u0000*\u0000epage\";s:3:\"749\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1473-3099\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:17:\"KWAKU POKU ASANTE\";s:10:\"\u0000*\u0000aufirst\";s:0:\"\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:41:{i:0;s:14:\"ABDULLA, Salim\";i:1;s:12:\"SALIM, Nahya\";i:2;s:17:\"FERNANDES, Jose F\";i:3;s:12:\"DOSOO, David\";i:4;s:14:\"CHIKAWE, Maria\";i:5;s:15:\"ISSIFOU, Saadou\";i:6;s:21:\"OSEI-KWAKYE, Kingsley\";i:7;s:13:\"LIEVENS, Marc\";i:8;s:14:\"PARICEK, Maria\";i:9;s:12:\"MOLLER, Tina\";i:10;s:15:\"APANGA, Stephen\";i:11;s:17:\"AGNANDJI, Selidji\";i:12;s:15:\"MWANGOKA, Grace\";i:13;s:20:\"DUBOIS, Marie-Claude\";i:14;s:12:\"MADI, Tigani\";i:15;s:12:\"KWARA, Evans\";i:16;s:11:\"MINJA, Rose\";i:17;s:20:\"HOUNKPATIN, Aurore B\";i:18;s:13:\"BOAHEN, Owusu\";i:19;s:15:\"KAYAN, Kingsley\";i:20;s:13:\"ADJEI, George\";i:21;s:20:\"CHANDRAMOHAN, Daniel\";i:22;s:11:\"LYIMO, John\";i:23;s:15:\"CARTER, Terrell\";i:24;s:16:\"VANSADIA, Preeti\";i:25;s:14:\"SILLMAN, Marla\";i:26;s:17:\"SAVARESE, Barbara\";i:27;s:16:\"LOUCQ, Christian\";i:28;s:16:\"LAPIERRE, Didier\";i:29;s:16:\"GREENWOOD, Brian\";i:30;s:10:\"COHEN, Joe\";i:31;s:15:\"KREMSNER, Peter\";i:32;s:17:\"OWUSU-AGYEI, Seth\";i:33;s:15:\"VEKEMANS, Johan\";i:34;s:14:\"TANNER, Marcel\";i:35;s:14:\"LELL, Bertrand\";i:36;s:24:\"SOULANOUDJINGAR, Solange\";i:37;s:11:\"OWUSU, Ruth\";i:38;s:17:\"SHOMARI, Mwanajaa\";i:39;s:13:\"LEACH, Amanda\";i:40;s:13:\"JONGERT, Erik\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:182:\"Safety and efficacy of the RTS,S\/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:23:\"Lancet Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"9\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
